Related content

Novel syngeneic mouse mammary carcinoma cell lines from aggressive ErbB2/Neu-overexpressing/PTEN-deficient tumors

By  

Oncology Reports, Vol. 33, Iss. 1, 2015-01 ,pp. : 179-184

Spandidos Publications

Access to resources Recommend Favorite

Trisomy chromosome 5 is a recurrent cytogenetic lesion in mammary tumors from parous MMTV-erbB-2 transgenic mice

By Kim Young Mi   Ma Zhikun   Lee Seungjik   Lee Jiyun   Li Shibo   Yang Xiaohe  

Oncology Letters, Vol. 2, Iss. 6, 2011-11 ,pp. : 1077-1081

Spandidos Publications

Access to resources Recommend Favorite

Role of cyclin D1 in ErbB2-positive breast cancer and tamoxifen resistance

By Ahnström Marie  

Breast Cancer Research and Treatment, Vol. 91, Iss. 2, 2005-05 ,pp. : 145-151

Springer Publishing Company

Access to resources Recommend Favorite

Dual role of AP-2 in ErbB-2-induced mammary tumorigenesis

By Jäger Richard   Friedrichs Nicolaus   Heim Inge   Büttner Reinhard   Schorle Hubert  

Breast Cancer Research and Treatment, Vol. 90, Iss. 3, 2005-04 ,pp. : 273-280

Springer Publishing Company

Access to resources Recommend Favorite

Co-Expression of ErbB-Family Members in Human Breast Cancer: Her-2/neu is the Preferred Dimerization Candidate in Nodal-positive Tumors

By Hudelist G.  

Breast Cancer Research and Treatment, Vol. 80, Iss. 3, 2003-08 ,pp. : 353-361

Springer Publishing Company

Access to resources Recommend Favorite